Skip to main content

Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis.

PMID: 29178871
Journal: RESPIRATORY RESEARCH
Year: 2017
Reference: Respir Res. 2017 Nov 25;18(1):196. doi: 10.1186/s12931-017-0683-x.
Impact factor: 3.841
Publication type: Paper in international publication
Authors: Miravitlles, Marc, Urrutia, Gerard, Mathioudakis, Alexander G, Ancochea, Julio et al.
DOI: 10.1186/s12931-017-0683-x

Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis.

PMID: 29178871
Journal: RESPIRATORY RESEARCH
Year: 2017
Reference: Respir Res. 2017 Nov 25;18(1):196. doi: 10.1186/s12931-017-0683-x.
Impact factor:
Publication type: Paper in international publication
Authors: Ancochea, Julio; Mathioudakis, Alexander G; Miravitlles, Marc; Urrutia, Gerard et al.
DOI: 10.1186/s12931-017-0683-x

Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis c.

PMID: 28039098
Journal: JOURNAL OF HEPATOLOGY
Year: 2017
Reference: J Hepatol. 2017 Apr;66(4):718-723. doi: 10.1016/j.jhep.2016.12.020. Epub 2016 Dec 28.
Impact factor: 10.59
Publication type: Paper in international publication
Authors: Forns, Xavier, Londono, Maria-Carlota, Calleja, Jose L, Crespo, Javier, Cuervas-Mons, Valentin, Fernandez, Inmaculada, Munoz-Gomez, Raquel, Pascasio, Juan M, Baliellas, Carme, Polanco, Natalia et al.
DOI: 10.1016/j.jhep.2016.12.020

Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis c.

PMID: 28039098
Journal: JOURNAL OF HEPATOLOGY
Year: 2017
Reference: J Hepatol. 2017 Apr;66(4):718-723. doi: 10.1016/j.jhep.2016.12.020. Epub 2016 Dec 28.
Impact factor:
Publication type: Paper in international publication
Authors: Arias, Ana; Baliellas, Carme; Calleja, Jose L; Castells, Lluis; Crespo, Javier; Cuervas-Mons, Valentin; Esforzado, Nuria; Fernandez, Inmaculada; Forns, Xavier; Hernandez, Olga et al.
DOI: 10.1016/j.jhep.2016.12.020

Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naive Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response.

PMID: 28056030
Journal: PLoS One
Year: 2017
Reference: PLoS One. 2017 Jan 5;12(1):e0168713. doi: 10.1371/journal.pone.0168713. eCollection 2017.
Impact factor: 2.806
Publication type: Paper in international publication
Authors: Craxi, Antonio, Asselah, Tarik, Moreno, Christophe, Sarrazin, Christoph, Gschwantler, Michael, Foster, Graham R, Bicer, Ceyhun, Lenz, Oliver, Van Dooren, Gino, Nalpas, Catherine et al.
DOI: 10.1371/journal.pone.0168713

Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naive Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response.

PMID: 28056030
Journal: PLoS One
Year: 2017
Reference: PLoS One. 2017 Jan 5;12(1):e0168713. doi: 10.1371/journal.pone.0168713. eCollection 2017.
Impact factor:
Publication type: Paper in international publication
Authors: Asselah, Tarik; Bicer, Ceyhun; Buggisch, Peter; Buti, Maria; Craxi, Antonio; Foster, Graham R; Gschwantler, Michael; Lenz, Oliver; Lonjon-Domanec, Isabelle; Moreno, Christophe et al.
DOI: 10.1371/journal.pone.0168713

Efficacy of beta-lactam/beta-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in hematological patients with neutropenia.

PMID: 28584145
Journal: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Year: 2017
Reference: Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00164-17. doi: 10.1128/AAC.00164-17. Print 2017 Aug.
Impact factor: 4.302
Publication type: Paper in international publication
Authors: Abdala, Edson, Akova, Murat, Alvarez, Rocio, Maestro-de la Calle, Guillermo, Cano, Angela, Cervera, Carlos, Clemente, Wanessa T, Martin-Davila, Pilar, Freifeld, Alison, Gomez, Lucia et al.
DOI: 10.1128/AAC.00164-17

Efficacy of beta-lactam/beta-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in hematological patients with neutropenia.

PMID: 28584145
Journal: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Year: 2017
Reference: Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00164-17. doi: 10.1128/AAC.00164-17. Print 2017 Aug.
Impact factor:
Publication type: Paper in international publication
Authors: Abdala, Edson; Akova, Murat; Alvarez, Rocio; Cano, Angela; Carratala, Jordi; Cervera, Carlos; Clemente, Wanessa T; Freifeld, Alison; Gomez, Lucia; Gottlieb, Thomas et al.
DOI: 10.1128/AAC.00164-17

Efficacy of immunomodulatory therapy with interferon-beta or glatiramer acetate on multiple sclerosis-associated uveitis.

PMID: 28188020
Journal: Archivos de la Sociedad Espanola de Oftalmologia
Year: 2017
Reference: Arch Soc Esp Oftalmol. 2017 Jun;92(6):273-279. doi: 10.1016/j.oftal.2016.11.018. Epub 2017 Feb 8.
Impact factor: 0
Publication type: Paper in national publication
Authors: Velazquez-Villoria, D, Macia-Badia, C, Segura-Garcia, A, Pastor Idoate, S, Arcos-Algaba, G, Velez-Escola, L, Garcia-Arumi, J et al.
DOI: 10.1016/j.oftal.2016.11.018

Efficacy of immunomodulatory therapy with interferon-beta or glatiramer acetate on multiple sclerosis-associated uveitis.

PMID: 28188020
Journal: Archivos de la Sociedad Espanola de Oftalmologia
Year: 2017
Reference: Arch Soc Esp Oftalmol. 2017 Jun;92(6):273-279. doi: 10.1016/j.oftal.2016.11.018. Epub 2017 Feb 8.
Impact factor:
Publication type: Paper in national publication
Authors: Arcos-Algaba, G; Garcia-Arumi, J; Macia-Badia, C; Pastor Idoate, S; Segura-Garcia, A; Velazquez-Villoria, D; Velez-Escola, L et al.
DOI: 10.1016/j.oftal.2016.11.018

Efficacy of laronidase therapy in patients with mucopolysaccharidosis type I who initiated enzyme replacement therapy in adult age. A systematic review and meta-analysis.

PMID: 28410878
Journal: MOLECULAR GENETICS AND METABOLISM
Year: 2017
Reference: Mol Genet Metab. 2017 Jun;121(2):138-149. doi: 10.1016/j.ymgme.2017.04.004. Epub 2017 Apr 9.
Impact factor: 3.769
Publication type: Paper in international publication
Authors: Perez-Lopez, Jordi, Morales-Conejo, Montserrat, Lopez-Rodriguez, Monica, Hermida-Ameijeiras, Alvaro, Molto-Abad, Marc et al.
DOI: 10.1016/j.ymgme.2017.04.004

Efficacy of laronidase therapy in patients with mucopolysaccharidosis type I who initiated enzyme replacement therapy in adult age. A systematic review and meta-analysis.

PMID: 28410878
Journal: MOLECULAR GENETICS AND METABOLISM
Year: 2017
Reference: Mol Genet Metab. 2017 Jun;121(2):138-149. doi: 10.1016/j.ymgme.2017.04.004. Epub 2017 Apr 9.
Impact factor:
Publication type: Paper in international publication
Authors: Hermida-Ameijeiras, Alvaro; Lopez-Rodriguez, Monica; Molto-Abad, Marc; Morales-Conejo, Montserrat; Perez-Lopez, Jordi et al.
DOI: 10.1016/j.ymgme.2017.04.004

Efficacy of loading dose of colistin in Acinetobacter baumannii ventilator-associated pneumonia.

PMID: 29286009
Journal: Le infezioni in medicina : rivista periodica di ez
Year: 2017
Reference: Infez Med. 2017 Dec 1;25(4):311-319.
Impact factor: 0
Publication type: Paper in international publication
Authors: Rello, Jordi, Alp, Emine, Eren, Esma, Elay, Gulseren, Cevahir, Fatma, Esmaoglu, Aliye et al.
DOI:

Efficacy of loading dose of colistin in Acinetobacter baumannii ventilator-associated pneumonia.

PMID: 29286009
Journal: Le infezioni in medicina : rivista periodica di ez
Year: 2017
Reference: Infez Med. 2017 Dec 1;25(4):311-319.
Impact factor:
Publication type: Paper in international publication
Authors: Alp, Emine; Cevahir, Fatma; Elay, Gulseren; Eren, Esma; Esmaoglu, Aliye; Rello, Jordi et al.
DOI:

Efficacy of neoadjuvant carboplatin plus docetaxel in triple negative breast cancer: Combined analysis of two cohorts.

PMID: 27301700
Journal: CLINICAL CANCER RESEARCH
Year: 2017
Reference: Clin Cancer Res. 2017 Feb 1;23(3):649-657. doi: 10.1158/1078-0432.CCR-16-0162. Epub 2016 Jun 14.
Impact factor: 8.738
Publication type: Paper in international publication
Authors: Lopez-Tarruella, Sara, Garcia-Saenz, Jose Angel, Ward, Claire, Connor, Carol, Gomez, Henry L, Prat, Aleix, Moreno, Fernando, Jerez-Gilarranz, Yolanda, Barnadas, Agusti, Picornell, Antoni et al.
DOI: 10.1158/1078-0432.CCR-16-0162

Efficacy of neoadjuvant carboplatin plus docetaxel in triple negative breast cancer: Combined analysis of two cohorts.

PMID: 27301700
Journal: CLINICAL CANCER RESEARCH
Year: 2017
Reference: Clin Cancer Res. 2017 Feb 1;23(3):649-657. doi: 10.1158/1078-0432.CCR-16-0162. Epub 2016 Jun 14.
Impact factor:
Publication type: Paper in international publication
Authors: Amin, Amanda; Barnadas, Agusti; Bretel Morales, Denisse; Connor, Carol; Cortes, Javier; Del Monte-Millan, Maria; Fabian, Carol J; Fuentes Rivera, Hugo; Garcia-Saenz, Jose Angel; Godwin, Andrew K et al.
DOI: 10.1158/1078-0432.CCR-16-0162

Efficacy of trifluridine and tipiracil (TAS-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic colorectal cancer from Spain: results of a subgroup analysis of the phase 3 RECOURSE trial.

PMID: 27443414
Journal: Clinical & Translational Oncology
Year: 2017
Reference: Clin Transl Oncol. 2017 Feb;19(2):227-235. doi: 10.1007/s12094-016-1528-7. Epub 2016 Jul 21.
Impact factor: 2.353
Publication type: Paper in international publication
Authors: Longo-Munoz, F, Argiles, G, Tabernero, J, Cervantes, A, Gravalos, C, Pericay, C, Gil-Calle, S, Mizuguchi, H, Carrato-Mena, A, Limon, M L et al.
DOI: 10.1007/s12094-016-1528-7

Efficacy of trifluridine and tipiracil (TAS-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic colorectal cancer from Spain: results of a subgroup analysis of the phase 3 RECOURSE trial.

PMID: 27443414
Journal: Clinical & Translational Oncology
Year: 2017
Reference: Clin Transl Oncol. 2017 Feb;19(2):227-235. doi: 10.1007/s12094-016-1528-7. Epub 2016 Jul 21.
Impact factor:
Publication type: Paper in international publication
Authors: Argiles, G; Carrato-Mena, A; Cervantes, A; Garcia-Carbonero, R; Gil-Calle, S; Gravalos, C; Limon, M L; Longo-Munoz, F; Mizuguchi, H; Pericay, C et al.
DOI: 10.1007/s12094-016-1528-7

Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 database.

PMID: 28660482
Journal: Clinical & Translational Oncology
Year: 2017
Reference: Clin Transl Oncol. 2017 Dec;19(12):1537-1542. doi: 10.1007/s12094-017-1700-8. Epub 2017 Jun 28.
Impact factor: 2.353
Publication type: Paper in international publication
Authors: de Castro, J, Remon, J, Isla, D, Garrido, P, Artal, A, Carcereny, E, Garcia-Campelo, M R, Lianes, P, Provencio, M, Juan, O et al.
DOI: 10.1007/s12094-017-1700-8

Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 database.

PMID: 28660482
Journal: Clinical & Translational Oncology
Year: 2017
Reference: Clin Transl Oncol. 2017 Dec;19(12):1537-1542. doi: 10.1007/s12094-017-1700-8. Epub 2017 Jun 28.
Impact factor:
Publication type: Paper in international publication
Authors: Artal, A; Blanco, R; Carcereny, E; de Castro, J; Diz, P; Felip, E; Garcia-Campelo, M R; Garrido, P; Isla, D; Juan, O et al.
DOI: 10.1007/s12094-017-1700-8

Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.

PMID: 27889312
Journal: LANCET NEUROLOGY
Year: 2017
Reference: Lancet Neurol. 2017 Jan;16(1):43-54. doi: 10.1016/S1474-4422(16)30292-7. Epub 2016 Nov 24.
Impact factor: 26.284
Publication type: Clinical Trials
Authors: Baulac, Michel, Rosenow, Felix, Toledo, Manuel, Terada, Kiyohito, Li, Ting, De Backer, Marc, Werhahn, Konrad J, Brock, Melissa et al.
DOI: 10.1016/S1474-4422(16)30292-7

Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.

PMID: 27889312
Journal: LANCET NEUROLOGY
Year: 2017
Reference: Lancet Neurol. 2017 Jan;16(1):43-54. doi: 10.1016/S1474-4422(16)30292-7. Epub 2016 Nov 24.
Impact factor:
Publication type: Clinical Trials
Authors: Baulac, Michel; Brock, Melissa; De Backer, Marc; Li, Ting; Rosenow, Felix; Terada, Kiyohito; Toledo, Manuel; Werhahn, Konrad J et al.
DOI: 10.1016/S1474-4422(16)30292-7

Electrochemical lateral flow devices: towards rapid immunomagnetic-assays

PMID: NOPMID001
Journal: ChemElectroChem
Year: 2017
Reference:
Impact factor: 4.136
Publication type: Paper in international publication
Authors: Ruiz-Vega, Gisela, Kitsara, Maria, Aller Pellitero, Miguel, Baldrich Rubio, Eva, del Campo, F. Javier et al.
DOI: 10.1002/celc.201600902

Electrochemical lateral flow devices: towards rapid immunomagnetic-assays

PMID: NOPMID001
Journal: ChemElectroChem
Year: 2017
Reference:
Impact factor:
Publication type: Paper in international publication
Authors: Aller Pellitero, Miguel; Baldrich Rubio, Eva; del Campo, F. Javier; Kitsara, Maria; Ruiz-Vega, Gisela et al.
DOI: 10.1002/celc.201600902